Investigational HIV Treatment Promising (CME/CE)

KUALA LUMPUR (MedPage Today) -- The investigational anti-HIV drug dolutegravir outperformed raltegravir (Isentress) in a randomized trial, a researcher said here.

Source: MedPage Today State Required CME - July 3, 2013 Category: Consumer Health News Source Type: news